VALN · Nasdaq · CIK 0001836564

Valneva SE

Valneva SE’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 15, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of EUR 174.7M and net income of -EUR 115.2M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
EUR 174.7M
Net income, FY2025
-EUR 115.2M
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
Valneva SE
Ticker
VALN
SEC Central Index Key (CIK)
0001836564
Business address
SAINT-HERBLAIN, France
State or country of incorporation
France
Fiscal year ends
December 31
SEC filer category
Accelerated filer
Position in SEC ticker list
#2899 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Valneva SE’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in EUR; the fiscal year is named for the calendar year in which it ends.

Revenue
EUR 348.1MFY2021EUR 361.3MFY2022EUR 153.7MFY2023EUR 169.6MFY2024EUR 174.7MFY2025
Net income
-EUR 73.4MFY2021-EUR 143.3MFY2022-EUR 101.4MFY2023-EUR 12.2MFY2024-EUR 115.2MFY2025
VALN annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
RevenueEUR 348.1MEUR 361.3MEUR 153.7MEUR 169.6MEUR 174.7M
Net income-EUR 73.4M-EUR 143.3M-EUR 101.4M-EUR 12.2M-EUR 115.2M
Diluted EPS-EUR 0.75-EUR 1.24-EUR 0.73-EUR 0.08-EUR 0.68
Total assetsEUR 817.4MEUR 621.3MEUR 460.1MEUR 500.0MEUR 398.8M
Cash and equivalentsEUR 3.0KEUR 286.5MEUR 126.1MEUR 168.3MEUR 109.7M

XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = Cash. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

VALN latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 17, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 15, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Valneva SE, by form type:

6-K ×29SCHEDULE 13D/A ×3EFFECT ×1424B3 ×1CORRESP ×1UPLOAD ×1F-3 ×1SCHEDULE 13G ×120-F ×16-K/A ×1
VALN recent filings
FiledFormWhat it isOriginal
Oct 15, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Oct 8, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Aug 14, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Aug 13, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 22, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Jun 25, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Jun 16, 2026EFFECTEFFECTDocument · Index
Jun 16, 2026424B3PROSPECTUSDocument · Index
Jun 12, 2026CORRESPCORRESPDocument · Index
Jun 11, 2026UPLOADUPLOADDocument · Index
Jun 5, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Jun 4, 2026F-3REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS BY CERTAIN FOREIGN PRIVATE ISSDocument · Index
Jun 1, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
May 13, 20266-KReport of a foreign private issuer· period Mar 31, 2026Document · Index
May 12, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 12, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
May 5, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Apr 30, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Mar 26, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Mar 23, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Mar 18, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Mar 17, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Mar 10, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Mar 9, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Mar 2, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Feb 19, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Feb 13, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Feb 3, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Jan 20, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Jan 9, 20266-KReport of a foreign private issuer· period Dec 31, 2026Document · Index
Dec 31, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Dec 11, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Nov 28, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Nov 26, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Nov 20, 20256-KReport of a foreign private issuer· period Sep 30, 2025Document · Index
Nov 4, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 6, 20256-K/A6-K/A· period Dec 31, 2025Document · Index
Oct 6, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 6, 20256-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Sep 5, 2025SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index

Insider filing activity

0 Form 4 filings appear in Valneva SE’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Biological Products, (No Diagnostic Substances)

All 61 companies in Biological Products, (No Diagnostic Substances)

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001836564 and XBRL company facts. Valneva SE on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.